CD8A and neoplasm: These molecules activate dendritic cells through pattern recognition receptors (e.g., toll like receptor 4 (TLR4) and interferon gene stimulating factor (STING)) to enhance the cross presentation of tumor associated antigens, thus recruiting and activating CD8+ T cells to establish tumor specific immune memory [17].